Deferiprone Tablet, Coated
Product Images NDC 0054-0576

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Deferiprone (NDC 0054-0576). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Deferiprone-chem-structure.jpg (Deferiprone Chem Structure)

Chemical structure of deferiprone showing a heterocyclic ring with oxygen, hydroxyl, and methyl functional groups.*

FDA Label Image

Deferiprone-tabs-bl-100s (Image 01)

Label for Deferiprone Tablets 500 mg oral coated tablets, distributed by Hikma Pharmaceuticals USA Inc. The label states the NDC 0054-0576-25 and package contains 100 tablets. It includes storage instructions to keep at 20° to 25°C and a pharmacist note to dispense the accompanying medication guide. The label features the Hikma logo and 'Rx only' marking.*

FDA Label Image

Deferiprone-tabs-bl-500mg-300s (Image 02)

Label for Deferiprone Tablets 500 mg, film-coated oral tablets. The container holds 300 tablets. Distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ. Includes storage instructions and a pharmacist reminder to dispense the Medication Guide. Barcode and NDC number 0054-0576-28 are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.